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Abstract
Background: Pathogen recognition by dendritic cells (DC) is crucial for the initiation of both innate and adaptive immune
responses. Activation of Toll-like Receptors (TLRs) by microbial molecular patterns leads to the maturation of DC, which
present the antigen and activate T cells in secondary lymphoid tissues. Cytokine production by DC is critical for shaping the
adaptive immune response by regulating T helper cell differentiation. It was previously shown by our group that Src kinases
play a key role in cytokines production during TLR4 activation in human DC.
Principal Findings: In this work we investigated the role of Src kinases during different TLRs triggering in human monocyte-
derived DC (MoDC). We found that Src family kinases are important for a balanced production of inflammatory cytokines by
human MoDC upon stimulation of TLR3 and 8 with their respective agonists. Disruption of this equilibrium through
pharmacological inhibition of Src kinases alters the DC maturation pattern. In particular, while expression of IL-12 and other
inflammatory cytokines depend on Src kinases, the induction of IL-23 and co-stimulatory molecules do not. Accordingly, DC
treated with Src inhibitors are not compromised in their ability to induce CD4 T cell proliferation and to promote the Th17
subset survival but are less efficient in inducing Th1 differentiation.
Conclusions: We suggest that the pharmacological modulation of DC maturation has the potential to shape the quality of
the adaptive immune response and could be exploited for the treatment of inflammation-related diseases.
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Introduction
The onset of adaptive immunity is initiated by the phagocytosis
of pathogens or their products by antigen-presenting cells (APCs),
which present the antigens in the form of a peptide-MHC complex
displayed on their surface to naı ¨ve T cells thus triggering the T cell
receptor (TCR) [1]. In addition to TCR engagement, the
interaction of co-stimulatory molecules on the APCs with their
respective receptors on the T cell is required for T cell activation
and proliferation [2–4]. Cytokines secreted by the dendritic cells
(DC) serve as the third signal in T cell activation and modulate T
cell differentiation into specific functional subsets. For example,
CD4+ T lymphocytes can polarize toward different T helper cell
types upon their activation. More than 20 years ago a series of
studies led to the formulation of the Th1/Th2 paradigm. Th1 cells
produce IFNc and facilitate the onset of response against
intracellular pathogens, while Th2 cells secrete mainly IL-4 and
mediate protection from extracellular microbial agents [5–7].
During these last years this paradigm was challenged by the
discovery of a new subset of T helper cells, the Th17 cells. This
subset is distinct from the classical Th1 and Th2 subsets, since
these cells produce IL-17, a pleiotropic inflammatory cytokine
involved in the induction of a variety of pro-inflammatory
mediators and adhesion molecules on various cell types. Recent
works suggest a key role for TGF-b, IL-1b and IL-6 in the lineage
commitment of Th17 cells [8–12]. However, the maintenance and
full effector functions of Th17 cells are strictly related to IL-23, a
heterodimeric cytokine [13] characterized by one specific subunit
(IL23A/p19) and a second component shared with IL-12 (IL-12B/
p40). Both IL-23 and IL-12 are induced in DC upon stimulation
with different microbial stimuli, but they seem to drive T cell
polarization in different directions. While IL-12 has a central role
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full effector functions of the Th17 subset [13]. It has been shown
that Th17 cells are critical in triggering inflammatory responses
and have a key role in autoimmune diseases, at least in the murine
model [14–16]. Other recent publications showed that Th17 cells
play an important role in the reduction of inflammation in
Helicobacter pylori-induced gastritis [17]. However, the exact role of
Th1/Th17 polarization in inflammation has not been clearly
elucidated yet.
The encounter between naı ¨ve T cells and antigen-loaded
mature DC in T cell areas of secondary lymphoid organs is the
first stage of T cell-based responses, and implies that DC
maturation is a crucial requirement for the initiation of adaptive
immunity [1]. The DC maturation process consists of the up-
regulation of co-stimulatory molecules, an increase in surface
peptide-MHC complex half-life and the production of inflamma-
tory cytokines, and is triggered by a broad range of pathogen-
associated molecular patterns (PAMPs). Most of these microbial
products act as stimuli for Toll-like receptors (TLRs), an
evolutionary conserved family of type-1 transmembrane receptors,
inducing the triggering of two main signaling pathways. The
majority of TLRs are characterized by the MyD88-dependent
signaling pathway, while TLR3 activation leads to the TRIF-
dependent cascade. TLR4 is the only member of the family that
makes use of both signaling pathways. Both pathways, however,
lead to the activation of transcription factors which are involved in
the induction of inflammatory cytokines [18,19].
Some evidences in the literature suggest an involvement of src-
family tyrosine kinases in the signaling pathway of TLRs [20] [21–
25]. In particular, it was recently demonstrated that Src kinases
have a role in cytokine production by human macrophages
stimulated with TLR agonists [21]. Earlier our group showed a
critical role for src-family kinases in TLR4 signaling leading to
cytokine production in monocyte-derived DC (MoDC) stimulated
by LPS [25]. PP1, a specific inhibitor of src-family tyrosine kinases,
was shown to block cytokine production in DC stimulated by LPS
without affecting the capacity of this pathogen component to up-
regulate the expression of MHC and co-stimulatory molecules on
the surface of these cells. As a consequence, DC were still capable
of stimulating T cell proliferation but were much less efficient in
inducing Th1 differentiation.
Here we investigated the role of src-family kinases in cytokine/
chemokine induction by triggering of TLRs other than TLR4. In
particular we focused on TLR3, characterized by the TRIF-
mediated signaling pathway, and on TLR8, which like the
majority of TLRs, makes use of the MyD88-dependent cascade.
We found that the Src kinase inhibitor PP2 was able to impair
cytokine production by MoDC upon activation of both TLRs
without affecting up-regulation of co-stimulatory molecules.
Microarray experiments were performed to identify gene expres-
sion profiles associated with this biological behavior in MoDC. We
found that stimulation of PP2-treated MoDC resulted in normal
IL-23 production associated to inhibition of IL-12, and this
molecular signature of Src kinases inhibition translated into a
functional effect on T cell activation.
Results
Src kinases inhibition impairs production of inflammatory
cytokines without affecting up-regulation of
co-stimulatory molecules
In a previous study [25] our group showed that Src kinases are
involved in signaling cascades leading to cytokine production upon
stimulation of TLR4 in human MoDC. Since TLR4 can signal
through both the MyD88-dependent and -independent pathways,
we asked if Src kinases play a role specifically in one of these
cascades, or if they are involved in the signaling of all TLRs. In
particular we focused on TLR3 for the TRIF-dependent and on
TLR8 for the MyD88-dependent pathways, respectively. We used
as agonists PolyI:C for TLR3 and R848 for TLR8. Although
R848 is known to activate both TLR7 and TLR8, only TLR8 is
triggered in human MoDC since these cells do not respond to pure
TLR7 agonists like Imiquimod. In accordance with previous
studies, which showed that Src kinases are phosphorylated upon
activation by TLR agonists [21,24,25], we found that Src
phosphorylation at the activation site (Tyr 416) was increased
when MoDC were stimulated with R848 and PolyI:C (Figure S1).
This phosphorylation was completely blocked by pretreatment of
the cells with PP2, a Src kinases inhibitor, demonstrating the in-
vivo specific activity of this compound (Figure S1). We then looked
at functional effect of PP2 pretreatment on human MoDC
stimulated with PolyI:C or R848. Treatment of MoDC with PP2
inhibited the secretion of the inflammatory cytokines TNFa and
IL-12p70 in response to both PolyI:C and R848 as demonstrated
by data from four independent experiments (Figure 1A), showing a
statistical significant difference (p,0,05) between the two exper-
imental groups. This impairment was associated to a normal
expression and up-regulation of the co-stimulatory molecule CD86
and of the DC maturation marker CD83 (Figure 1B). In dose
response experiments, pre-treatment with PP2 inhibited the
secretion of IL-12p70, TNFa and other inflammatory cytokines
such as IL-1b and IL-6, even at high concentrations of the
agonists. Data from three independent experiments expressed as
average fold induction with a statistical significant difference
(p,0,05) between the two experimental groups are shown in
Figure 1C. Moreover, since one of the outcomes of the TLR3-
TRIF-dependent pathway is type I IFN production, we assessed
the role of Src kinases on the induction of IFNb. We found that
IFNb was induced only in PolyI:C-stimulated cells, and this
production was greatly impaired by Src kinases inhibition (Figure
S2). These results confirmed that Src kinases play a key role in
both TLR3 and TLR8 signaling pathways.
Src kinases play a key role in the accumulation of c-Jun
and IRF1
We then asked which is the role of Src-family kinases in the
intracellular signaling pathways triggered by TLR3 and TLR7/8.
Both the MyD88 and TRIF-dependent cascades are known to
activate NF-kB, ERK and JNK pathways. As an indication of NF-
kB activation after stimulation with R848 and PolyI:C we
monitored the degradation of IkB, and we found that it was not
inhibited by treatment with PP2 (Figure 2 and Figure S3). On the
contrary, in PP2-treated cells stimulated with PolyI:C there was a
delayed reappearance of IkB that could be explained by its
sustained degradation at later time points. In fact no effect of PP2
on TLR3-induced transcription of IkB (NFKBIA gene) could be
observed in microarray experiments (Table 1 and Table S1). This
finding indicates that Src kinases do not have a negative role in the
activation of the NF-kB pathway. We also found that PP2 did not
inhibit ERK phosphorylation (Figure 2), or p38 phosphorylation
(data not shown) induced by TLR3 or TLR8 activation. By
contrast, pretreatment of MoDC with PP2 inhibited c-Jun
phosphorylation and stabilization upon stimulation with R848 or
PolyI:C (Figure 2 and Figure S3A). The relevance of this
observation is shown by the densitometric analysis of three
independent Western blot experiments and the statistical signifi-
cant difference (p,0,05) between the two experimental groups
(Figure S3B). This demonstrates that Src kinases play an important
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which, as a component of the AP-1 complex, regulates the
expression of the majority of cytokines upon TLR engagement.
Induction of IRF1, another transcription factor known to control
many cytokine genes, was also impaired by PP2 treatment (Figure 2
and Figure S3A). Again the densitometric analysis of three
independent Western blot experiments and the statistical signifi-
cant difference (p,0,05) between the two experimental groups
(Figure S3B) demonstrate the relevance of src kinases for the
induction of this transcription factor. Recently Zanoni et al [26]
showed that stimulation of murine dendritic cells with LPS
resulted in influx of extracellular calcium and activation of NFAT
through a pathway that is CD14-dependent and TLR4-indepen-
dent. We therefore tested if TLR3 or TLR8 stimulation could
result in the activation of this pathway. However, we found that
stimulation of human MoDC with PolyI:C or R848 did not induce
any calcium influx in these cells, confirming that TLRs do not
directly activate an intracellular pathway that results in an increase
of calcium levels (data not shown). All together these data suggest
that Src kinases may play a key role in modulating cytokine
induction in response to TLR agonists, through the regulation of
key transcription factors.
Src kinases inhibition differentially affects gene
expression profiles in stimulated MoDC
To further study the role of Src kinases in both the MyD88 and
TRIF-dependent pathways, we performed a transcriptional
analysis of cells stimulated with TLR3 and TLR8 agonists in the
presence or in the absence of PP2. First, the transcriptome of
MoDC stimulated for 4 hours with PolyI:C or R848 was
compared to the transcriptome of non-stimulated cells to identify
all TLR3 and TLR8 responsive genes, respectively. By using a
threshold of 4-fold up-regulation with a pvalue#0.05 across three
different MoDC donors we identified 145 TLR3 (Table S1) and
151 TLR8 (Table S2) dependent reporters. In order to evaluate
the impact of PP2 treatment on these genes a second microarray
experiment was performed using MoDC from the same donors. In
this experiment the transcriptome of MoDC pre-treated with PP2
and stimulated with PolyI:C or R848 for 4 hrs was compared with
the transcriptome of corresponding MoDC stimulated in the
absence of PP2.
Approximately 42% of the Poly:IC up-regulated genes and 54%
of the genes up-regulated by R848, were inhibited more than 50%
by PP2 (Figure 3). Among these inhibited genes we found
cytokine-encoding genes like IL-12B, TNFa, IL-6 and the
transcription factor IRF8 (Table 1). Consistently with western blot
experiments, among the genes that were not affected by treatment
with PP2 we found genes that are regulated by the NF-kB
pathway, such as the NF-kB inhibitor and other members of the
NF-kB family. Therefore this last finding strengthens our
hypothesis that Src kinases are not involved in the NF-kB family
pathways. Unexpectedly, transcription of the IL-1B gene was not
dramatically impaired in PP2 treated cells, although the release of
this cytokine upon TLR stimulation was regulated by Src kinases
(Figure 1). These data suggest that Src kinases can modulate IL-1
production by a post-transcriptional mechanism.
IL-23 and IL-12 are two homologous cytokines characterized by
a common p40 chain (IL-12B) and another chain specific for each
cytokine (IL-12A or IL-23A). We found that the gene encoding the
alpha subunit of the cytokine IL-23 (IL-23A) was not inhibited
following pharmacological blockade of Src kinases in MoDC
stimulated with either PolyI:C or R848 (Table 1). Surprisingly,
pre-treatment with PP2 resulted in an even higher up-regulation of
IL-23A mRNA by R848 (2-fold more compared to R848
stimulated cells). In contrast, the induction of IL-12B by either
PolyI:C or R848 was inhibited by PP2 more than 80% (Table 1).
No conclusion on IL-12A transcription could be obtained from
microarray data due to a high variability of the results among
different donors.
To validate microarray data and to better investigate the
relationship between IL-12 and IL-23 subunits, we performed a
qRT-PCR on MoDC pretreated or not with PP2 and stimulated
for 4 hours with either PolyI:C or R848. These experiments
confirmed microarray data showing that transcription of IL-6,
TNFa and IL-12B was dramatically impaired in PP2-treated cells
after 4 hours of stimulation with PolyI:C or with R848 as
demonstrated by data from four (with PolyI:C) or three (with
R848) independent experiments showing a statistical significant
difference (p,0,05) between the two experimental groups
(Figure 4A). On the contrary, the induction of IL-23A was not
inhibited but most of the time enhanced upon Src kinases
inhibition by PP2 (Figure 4A), although there was no statistical
significant difference (p.0,05) between the two experimental
groups. In order to identify the mechanism responsible for the
different effect of Src kinases inhibition in the expression of IL-12
and IL-23 subunits, we focused our attention on the factors that
regulate the transcription of these cytokines. It is known that IRF8
is a key transcription factor for production of IL-12, IL-6 and TNFa
[27,28], while recent evidence shows that transcription of the IL-
23A subunit is mainly regulated by the NF-kB family member, c-
Rel [29,30]. Indeed qRT-PCR data from three independent
experiments showed that in both MoDC stimulated with PolyI:C
or R848, c-Rel transcription was not affected by treatment with
PP2 (no statistical significant difference (p.0,05) between the two
experimental groups was observed), while IRF-8 up-regulation was
impaired upon inhibition of Src kinases with a statistical significant
difference (p,0,05) between the two experimental groups
(Figure 4B). These data, which confirmed the microarray data
(Table 1), suggest that Src kinases activity modulate IRF8
responsive genes induced by TLR agonists.
Src kinases inhibition decreases the production of IL-12
in response to TLR agonists but does not affect the
production of IL-23
The finding that IL-23A gene transcription is not inhibited upon
treatment with PP2, while expression of its beta subunit is
inhibited, raises the question of which is the effect of Src kinases on
IL-23 protein production. We tested supernatants of DC after 24-
Figure 1. Src kinases inhibition results in uncoupling of cytokines production from up-regulation of co-stimulatory molecules. (A
and B) Human MoDC were pretreated or not with PP2 (20 mM) and stimulated with PolyI:C (20 mg/ml) or R848 (10 mM). (A) Cytokines released in the
supernatants were detected after 24 hours of stimulation. Fold induction for the levels of each cytokine compared to unstimulated cells is plotted.
Data from four independent experiments and the p values for the differences between the two experimental groups are shown (p value ,0.05 is
significant). (B) Surface expression of CD83 and CD86 was analyzed by flow cytometry after 36 hours of stimulation. Stimulated cells are represented
with black line histogram, PP2-treated and stimulated cells are in grey line and untreated cells are in filled grey histogram. (C) MoDC were pretreated
(open symbols) or not (filled symbols) with PP2 (20 mM) and stimulated with increasing concentrations of PolyI:C and R848. Cytokines production was
analyzed at 24 hours. Average fold induction of three independent experiments for the levels of each cytokine compared to unstimulated cells is
plotted and the p values for the differences between the groups are shown (p value ,0.05 is significant).
doi:10.1371/journal.pone.0011491.g001
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R848 PolyI:C
Gene Symbol Fold change Effect of PP2 (%) Fold change Effect of PP2 (%)
Transcription activity (validated genes)
IRF8 4,8 280,25 5,24 264,05
NFKBIA 4,65 9,8
REL 5,72 26,55
Cytokines (validated genes)
IL12B 91,06 285,66 45,06 281,13
IL8 33,25 282,69 11,81 265,82
IL6 65,90 273,79 88,99 253,31
TNF 17,01 266,29 19,07 263,49
TNF 20,93 234,13 26,54 221,29
IL23A 41,41 101,86 18,35 6,13
Other Cytokines
CCL1 8,53 288,53 14,43 293,93
IL1A 53,18 292,43 86,91 284,43
CSF2 10,97 277,38 7,20 283,72
CCL20 69,15 277,37 57,19 270,98
CXCL2 12,91 241,72 16,90 262,35
CXCL3 20,64 239,57 24,26 261,42
CXCL3 15,03 242,76 16,44 260,23
CXCL2 16,33 242,23 27,82 256,26
IL7R 6,83 249,28 5,21 248,97
CXCL1 83,24 220,43 109,78 245,66
IL10 9,68 283,11 3,66 236,78
IL15RA 10,64 243,74 18,64 220,84
CCL5 13,92 245,39 27,91 219,20
CLCF1 14,92 3,04 14,50 218,40
IL1B 12,07 214,90 40,98 29,67
CCL4 6,37 227,14 5,71 1,98
IL1F9 27,77 293,87
IL19 12,45 292,34
CXCL9 4,03 221,66
CXCL11 5,28 231,80
CXCL11 26,54 259,31
IL18RAP 5,00 259,83
IL28A 44,15 261,07
IL28B 188,72 273,24
CCL3L3 52,43 274,54
CCRL2 153,81 276,58
CCL3L3 158,11 277,24
IFNB1 58,28 282,31
Cytokine and transcription factor genes whose expression is up-regulated upon stimulation with R848 or PolyI:C. Expression of some genes was validated by qRT-PCR.
Fold induction upon TLR stimulation and the effect of PP2 for each stimulus is indicated. Blank spaces indicate that genes were up-regulated less than 4-fold upon
stimulation. Some genes are indicated twice because two reporters were present in the array.
doi:10.1371/journal.pone.0011491.t001
Figure 2. Src kinases are required for accumulation of c-Jun and IRF1. Human MoDC were pretreated or not with PP2 (20 mM) and
stimulated with PolyI:C (20 mg/ml) or R848 (10 mM) for the indicated time. IkB, phospho-ERK, phospho-cJun and IRF1 were detected by WB on total
cell lysates. After stripping filters were re-blotted with antibodies to Actin, total ERK, total cJun and Actin, respectively. When samples from a single
experiment were loaded on two different gels, a black line separates images obtained from the two separate blots. All data are representative of at
least three experiments.
doi:10.1371/journal.pone.0011491.g002
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23 presence. We observed that stimulation of TLR3 and TLR8
results in striking differences in the secretion of IL-12 and IL-23:
PolyI:C leads to a higher secretion of IL-12p70, while R848
preferentially induces IL-23 production (Figure 5A). As already
observed in Figure 1A, we found that PP2 was able to impair IL-
12 production, but unexpectedly did not affect IL-23 production
following both TLR stimulations as shown by data from four
independent experiments and their statistical analysis (Figure 5A).
This differential effect of PP2 on the production of IL-12p70 and
IL-23 was observed also at lower concentrations of inhibitor
(Figure S4).
This result appears in conflict with data showing impaired up-
regulation of the IL-12B mRNA, which should result in a
decreased production of both IL-12 and IL-23. However, a direct
comparison of IL12B and IL23A mRNA levels measured by qRT-
PCR revealed that even in PP2 treated cells the mRNA levels of
IL12B are higher compared to IL23A (Figure 5B). This
observation suggests that in the assembling of the IL-23 the p40
subunit is in excess compared to the p19 subunit, while the latter is
likely the limiting component. Indeed, a great excess of IL-12p40
compared to total IL-23 could be detected by ELISA in the
supernatants of stimulated MoDC, even after Src kinases
inhibition (Figure 5C). On a molar base the excess of IL-12p40
varied from 322 to 30 fold after R848 stimulation, and from 26 to
9 after PolyI:C stimulation, in the absence and in the presence of
PP2, respectively. This model, which indicates that p19 is the only
limiting subunit for the assembly of IL-23, accounts for the
absence of any decrease in the levels of total IL-23 cytokine
following treatment with PP2. It was then critical to analyze what
is the effect of Src kinases inhibition on the expression of IL-12A
(p35) subunit of active IL-12 upon TLR agonist stimulation in
MoDC. qRT-PCR analysis showed that PP2 was able to impair
IL-12A up-regulation in R848-stimulated cells (Figure S5A) but
not in PolyI:C stimulated cells. However, a direct comparison of
IL-12B and IL-12A mRNA levels suggests that while reduction of
IL-12p70 levels in R848-stimulated cells reflects the inhibition of
both subunits, in PolyI:C stimulated cells IL-12A is in excess and
IL-12B is very likely the limiting subunit (Figure S5B), thus
influencing the protein levels of active IL-12p70. Unfortunately,
this hypothesis could not be tested by an absolute measurement of
monomeric IL-12A protein levels, since no-reagent for the
detection of this subunit is available.
Dendritic cells express different TLRs and thus can be
simultaneously activated by different PAMPs. Indeed, it was
reported that a concurrent engagement of TLR8 with either
TLR4 or TLR3 results in a synergistic effect on cytokine
production [31]. We investigated if Src kinases can modulate
cytokine production in MoDC even after simultaneous TLR
activation. Cytokines were measured following MoDC stimulation
with increasing concentrations of R848 and LPS, alone or
simultaneously. As previously reported, a remarkable enhance-
ment in the production of TNFa (data not shown), IL-12 and IL-
23 (Figure 5D) was observed when both stimuli were provided.
The synergistic effect on IL-12 production was completely
abolished by inhibition of Src kinases, while no effect was observed
on the synergistic production of the IL-23 cytokine, showing that
activation of Src kinases is required for a balanced production of
inflammatory cytokines in DC upon stimulation by multiple TLR
agonists. IL-27 is a dimeric cytokine member of the IL-12 family
and it has been described as a negative regulator of Th17 subset
development [32]. It is constituted by a p28 and EBI3 subunits,
paralogs of IL-12A and IL-12B, respectively. Because of its
homology with IL-12, it was relevant to investigate the effect of
PP2 on this cytokine. Indeed, we found that IL-27 production was
not affected by Src kinases inhibition neither in PolyI:C nor in
R848-stimulated cells (Figure S6).
Src kinases inhibition compromises Th1 differentiation
but does not impair the ability of MoDC to promote the
survival of Th17 cells
Our data clearly show that Src kinases play an important role in
cytokine production by MoDC upon stimulation with different
TLRs. However, inhibition of Src kinases in these cells has a
different impact on the production of IL-12 or IL-23. These two
cytokines exert different, if not opposite functions during an
immune response. While the bioactive form of IL-12, IL-12p70, is
critical for differentiation of naı ¨ve T cells towards a Th1 cell type
[33,34], IL-23 is responsible for maintenance and survival of Th17
cells. We investigated if the imbalanced production of cytokines
caused by Src kinases inhibition, translates into a functional effect
on differentiation and maintenance of different T helper cell
subsets. To asses the effect of Src kinases inhibition on the ability
of MoDC to induce proliferation of naı ¨ve T cells, we co-cultured
PolyI:C- and R848-stimulated MoDC, which were previously pre-
treated or not with PP2, with allogeneic naı ¨ve T cells for 4 days, in
the presence of the superantigen TSST-1. We found that
proliferation of naı ¨ve T cells was not affected by treatment of
MoDC with PP2 (Figure 6A). This result is in agreement with the
finding that induction of co-stimulatory molecules on DC did not
Figure 3. Graphical representation of gene expression modulation by Src kinases inhibition. Human MoDC were pretreated or not with
PP2 (20 mM), stimulated with PolyI:C (20 mg/ml) or R848 (10 mM) for 4 hours, and gene expression was assessed by Microarrays. Inhibition of gene
expression by PP2 treatment was analyzed on genes which were up-regulated at least 4-fold upon stimulation, with a p value ,0.05.
doi:10.1371/journal.pone.0011491.g003
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inhibition on the capacity of MoDC to shape polarization of naı ¨ve
T cells was then evaluated. Naı ¨ve T cells were incubated for 7
days with MoDC supernatants in the presence of anti-CD3/CD28
antibodies, and then re-stimulated for other 7 days with anti-
CD3/CD28 to expand polarized T cells. At day 14 supernatants
from these T cells cultures were tested for IFNc and IL-17. While
supernatants from DC stimulated with R848 increased the levels
of IFNc production in naı ¨ve T cells - indicating a Th1 shift - we
detected an impairment of this differentiation in T cell cultures
containing supernatants from DC stimulated after inhibition of
Src kinases. Impairment of Th1 cell differentiation was associated
to an increase in IL-17 production by naı ¨ve T cells (Figure 6B). In
case of supernatants from PolyI:C-stimulated DC, they were able
to induce a big Th1 polarization that was blunted when DC were
inhibited by PP2 (Figure 6B). However no IL-17 was detected in
naı ¨ve T cells differentiated in the presence of supernatants from
PolyI:C-stimulated DC when Src kinases were inhibited. This
discrepancy between the results obtained with the two stimuli can
be explained by the fact that in R848-stimulated cells the IL-12/
IL-23 balance is shifted towards IL-23 production and this could
be an important factor for the differentiation into Th17 cells. On
the contrary, in PolyI:C stimulated cells, the low levels of IL-23
compared to IL-12p70 are probably not sufficient to promote a
Th17 shift of naı ¨ve CD4 T cells in vitro and that other factors are
required, as previously showed by other studies [9–12]. To asses
the effect of Src kinases inhibition on the capacity of MoDC to
sustain the differentiation and survival of pre-polarized T helper
cells, we stimulated total CD4+ T cells with anti-CD3 and anti-
CD28 for 7 days in the presence of supernatants from MoDC
which were stimulated by a single TLR agonist or a combination
of TLR stimulators in the presence or not of Src kinase inhibition.
CD4+ T cells were then re-stimulated with anti-CD3/CD28 for 7
additional days, and supernatants collected at day 14 were tested
for IFNc and IL-17 (Figure 6C). Supernatants form stimulated
MoDC induced IFNc production by CD4+ T cells in all cases
(PolyI:C, R848 and LPS+R848 stimulation of DC) but IFNc levels
were dramatically reduced when MoDC were pretreated with
PP2. This reduction was associated to an increase in IL-17
production, likely indicating a better survival of the Th17 subset
compared to the Th1 subset (Figure 6C). This shift occurred
despite the presence of IL-27, a negative regulator of Th17 cells,
in the supernatants of DC. Indeed, we found that IL-27
production was not affected by Src kinases inhibition neither in
PolyI:C nor in R848-stimulated cells (Figure S6). This finding is in
agreement with a well established role of IL-23 in survival of
memory Th17 cells. We also tested if the homing capacity of
CD4+ T cells incubated with supernatants of DC was affected by
inhibition of Src kinases. For this purpose we analyzed the surface
expression of CCR6, CCR5, CCR9 and CXCR3 on CD4+ T
cells that were stimulated as in Figure 6C. However, there was no
significant difference in the expression of all four chemokine
receptors on CD4+T cells incubated with supernatants from
PolyI:C or R848 stimulated DC in the presence and in the
absence of PP2 (data not shown), suggesting that the homing
capacity of T cells was not affected by Src kinases inhibition in
MoDC.
Discussion
In this paper we discuss the role of Src family kinases in cytokine
production by human DC upon stimulation with TLR agonists.
Cytokine production is a major feature of DC maturation and it is
critical in triggering T cell activation. We previously showed that
activation of Src kinases is a key step in TLR4 signaling in MoDC.
Inhibition of Src kinases indeed resulted in a block of
inflammatory cytokine release resulting in a clear impairment of
Th1 differentiation [25]. TLR4 signaling is characterized by both
MyD88- and TRIF-dependent signaling cascades. In this study, in
order to dissect the role of Src kinases activation in the TRIF- and
MyD88-dependent pathways we investigated the effects of Src
kinases inhibitor PP2 in MoDC stimulated with TLR3 or TLR8
agonists. We demonstrated that following TLR3 and TLR8
activation, Src kinases control the activation of c-Jun and IRF1,
while have no effect on NF-kB and ERK signaling cascade.
Additionally, the microarray analysis presented here, confirmed by
the qRT-PCR and secreted cytokines analyses, showed that Src
kinases inhibition had a similar effect on the transcriptional
changes induced by TLR3 and TLR8 activation excluding a
pathway-specific involvement of these kinases in the TRIF or
MyD88 signaling cascades. In particular, we found that Src
kinases modulate the expression of several cytokines including
IL12, TNFa and IL6. As previously observed for TLR4, inhibition
of Src kinases had no effect on the induction of a maturation
phenotype upon stimulation by PolyI:C or R848, resulting in DC
still able to induce naı ¨ve T cell proliferation. These data show that
Src kinases control only some specialized aspects of the DC
maturation process and that these kinases have a central role in the
induction of most of the inflammatory cytokines, but not in the
production of IL-23.
IL-23 is an inflammatory cytokine produced by mature DC,
which was shown to support survival and full effector functions of
Th17 cells, a new identified T helper population characterized by
the production of IL-17 [13]. These cells have been implicated in
the pathogenesis of autoimmune diseases [8,35,36]. Interestingly,
IL-23 shares high homology with IL-12, the key cytokine
responsible for Th1 differentiation as the IL-12p40 subunit (IL-
12B) can either be associated to IL-12p35 (IL-12A) or to IL-23p19
(IL-23A), forming the bioactive form of IL-12 or IL-23,
respectively. We show that Src kinases control the induction of
the IL-12p40 subunit, but have no role in the transcription and
production of the IL-23A subunit. Thus, inhibition of Src kinases
results in a severe imbalance in the IL-12/IL-23 axis, revealing a
peculiar role for Src kinases in cytokine production. In agreement
with the cytokine expression data we observed that Src kinases
inhibition affects the up-regulation of the transcription factor
IRF8, which controls the expression of inflammatory cytokines
such as IL-12 and TNFa, bus does not impair the induction of
cRel, which regulates the expression of the IL-23A subunit.
IL-12 and IL-23 have different effects on T helper cell
differentiation and survival. It was therefore of paramount
importance to establish if the observed IL-12/IL-23 imbalance
would result in a functional effect on the type of immune response.
We showed that a variation in the IL-12/IL-23 ratio has
consequences on the polarization or survival of T helper cells.
MoDC in which IL-12p70 production was impaired due to Src
Figure 4. Src kinases inhibition does not affect expression of IL-23A and cREL. MoDC were pretreated or not with PP2 (20 mM) and
stimulated with PolyI:C (20 mg/ml) or R848 (10 mM) for 4 hours. qRT-PCR was performed to analyze expression of cytokine genes (A) or transcription
factor genes (B). Fold induction for the expression of each gene compared to unstimulated cells is plotted. Expression levels for each analyzed gene
were normalized to b-Actin. Three or four independent experiments and the p values for the differences between the groups are shown (p value
,0.05 is significant).
doi:10.1371/journal.pone.0011491.g004
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PLoS ONE | www.plosone.org 10 July 2010 | Volume 5 | Issue 7 | e11491kinases inhibition are less efficient in inducing differentiation of
naı ¨ve T cells into Th1 cells. This is in agreement with a role for IL-
12 as a Th1-polarizing cytokine. Many groups have showed that
Th17 cells can be induced from naı ¨ve T cells by culturing these
cells with a cocktail of inflammatory cytokines such as IL-1b, IL-6
and TGFb, and that IL-23 is necessary but not sufficient for the
differentiation of Th17 cells [9–12]. As we have shown that Src
kinases inhibition results in impairment not only of IL-12 but also
of IL-6, IL-1b and TNFa production, we would have expected
that under this condition we could not induce detectable levels of
IL-17-producing T cells from naı ¨ve precursors. Never the less,
supernatants of R848-stimulated DC were able to trigger IL-17
production from naı ¨ve T cells, likely because of the high levels of
IL-23 induced in comparison to other stimuli, and IL-17 was
further increased when src kinases were inhibited in MoDC. On
the other hand, Oppman et al showed that the main biological
effects of IL-23 can be observed on survival of memory Th17 cells
and not on naı ¨ve T cells [13]. We show that co-culturing of total T
Figure 6. Imbalanced IL-12/IL-23 production results in a functional effect on T cells activation. (A) MoDC were pretreated or not with PP2
(20 mM), stimulated with PolyI:C (20 mg/ml) or R848 (10 mM) for 6 hours, washed extensively and cultured with CFSE-labeled heterologous naı ¨ve CD4+
T cells in the presence of the superantigen TSST-1 (25 pg/ml). (B–C) MoDC were pretreated or not with PP2 (20 mM), stimulated with PolyI:C (20 mg/
ml), R848 (10 mM) or LPS (100 ng/ml)+R848 for 6 hours, washed extensively and cultured in fresh medium for 48 hours. After 48 hours supernatants
were collected and added to naı ¨ve CD4+ T cells (B) or total CD4+ T cells (C), in the presence of anti-CD3 and anti-CD28 antibodies. After 7 days of
incubation, T cells were restimulated with anti-CD3 and anti-CD28 and incubated for 7 additional days. At day 14, supernatants were collected and IL-
17 and IFNc were detected by ELISA or Mesoscale assays, respectively. Data from three independent experiments are shown.
doi:10.1371/journal.pone.0011491.g006
Figure 5. Src kinases inhibition results in imbalanced IL-12/IL-23 production. (A-C) MoDC were pretreated or not with PP2 (20 mM) and
stimulated with PolyI:C (20 mg/ml) or R848 (10 mM). (A) IL-12p70 and IL-23 release in the supernatant after 24 hours of stimulation was measured by
ELISA. Fold induction for the levels of each cytokine compared to unstimulated cells is plotted. Data from four independent experiments and the p
values for the differences between the groups are shown (p value ,0.05 is significant). (B) qRT-PCR for IL-12B and IL-23A genes was performed after
4 hours of stimulation and expressed as fold increase over basal expression in unstimulated cells. Numbers indicates values of fold induction for each
column. (C) IL-12p40 and IL-23 release in the supernatant after 24 hours of stimulation was measured by ELISA. Numbers indicates values of pg/ml for
each column. (D) MoDC were pretreated or not with PP2 (20 mM) and stimulated with increasing combined doses of LPS and R848. IL-12p70 and IL-23
release in the supernatant after 24 hours of stimulation was measured by ELISA. Average fold induction of four independent experiments for the
levels of each cytokine compared to unstimulated cells is plotted, and the p values for the differences between the groups are shown (p value ,0.05
is significant).
doi:10.1371/journal.pone.0011491.g005
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survival of Th17 cells. The increase in IL-17 production was
associated to a dramatic decrease in IFNc release, suggesting that
Src kinases inhibition can produce a shift from Th1 to Th17 cells.
Th17 cell subset has been suggested to be a major player in the
pathogenesis of autoimmune diseases. This hypothesis is based on
a series of studies on both knockout mice and human samples from
patients affected by autoimmune diseases. However, a recent study
claims that Th17 cells could have an anti-inflammatory role in
H.Pylori-induced gastritis in mice [17]. Another study has also
lately challenged the notion about a pathogenic role of Th17 cells
in autoimmune inflammation. Flavell and coworkers showed that
IL-17 has a protective function in a mouse model of inflammatory
bowel disease by down-regulation of Th1 specific gene expression
and a modulation of T cell mediated colon inflammation [37].
Thus, the role of Th17 in inflammation and autoimmune diseases
has not yet been definitively elucidated. Our findings showing that
the pharmacological modulation of DC maturation by Src
inhibitors can inhibit Th1 responses without affecting Th17
differentiation could be used as the basis of further investigations
aimed at exploiting the potential use of these drugs for the
treatment of inflammatory diseases.
Materials and Methods
Donors
Buffy coats from healthy donors were obtained from the Blood
Transfusion Section, Alta Val D’Elsa Hospital (Poggibonsi, Italy).
Informed consent was obtained before all blood donations. The
study protocol was approved by the Novartis Research Center
ethical committee and conforms to the ethical guidelines of the
1975 Declaration of Helsinki.
Cell culture and reagents
PBMC were isolated from buffy coats of healthy donors using
Ficoll gradient. Monocytes were isolated from PBMC with anti-
CD14 magnetic beads (Miltenyi Biotec) and cultured with human
recombinant GM-CSF (50 ng/ml) (Gentaur) and human recom-
binant IL-4 (5 ng/ml) (Gentaur) for 5–7 days. Differentiation of
monocytes to Dendritic cells was routinely assessed by Flow
cytometry detection of CD14 and CD1a surface molecules: only
DC populations that showed no expression of CD14 and an
expression of CD1a higher than 70% were used for the
experiments. The culture medium was RPMI 1640 (GIBCO)
supplemented with 2 mM L-glutamine, 1% sodium pyruvate, 1%
nonessential amino acids, 100 g/ml kanamycin (GIBCO),
5610
25 M 2-mercaptoethanol (Sigma) and 10% heat-inactivated
fetal calf serum (Hyclone). Naı ¨ve T cells and total CD4+ T cells
were isolated from PBMCs by negative selection using magnetic
beads based kits from Miltenyi Biotec. T cells were cultured in
IMDM (GIBCO) supplemented with Penicillin-Streptomycin-
Glutamine (GIBCO), and 10% heat-inactivated fetal calf serum
(Hyclone). PP2 was purchased from Alexis and added to MoDC
used 20 min before stimulation with TLR agonists. PolyI:C was
from Invivogen, while LPS and R848 were purchased from Alexis.
For T cell proliferation, naive CD4
+ T cells were labeled with
CFSE (Invitrogen) at 0,5 mM. Polyclonal T cells stimulation was
induced with anti-CD3 and anti-CD28 (from BD Biosciences) at
1 mg/ml. TSST-1 was purchased from Sigma Aldrich.
Flow cytometry
Flow cytometry was performed on FacsCanto or FACS LSRII
instruments using DIVA software (Becton Dickinson) and data
were analyzed using Flowjo software (Treestar Inc.). Proliferation
of naı ¨ve T cells was evaluated after measuring dilution of CFSE
fluorescence. MoDC phenotypic maturation was evaluated by
extracellular staining with anti-CD83-FITC and anti-CD86-APC
(BD Biosciences).
Cytokine detection
Mesoscale Assay Human-Proinflammatory 7-spot, Human
IFNb single-spot and Human TH1/TH2 7-spot kits (MSD
Technology) were used for detection of inflammatory cytokines
and of polarizing cytokines, respectively, following manufacturer’s
instructions. Sandwich ELISA using matched paired antibodies
was performed for detection of IL-23, IL-12p40, IL-12p70, IL-
17A (eBioscience) and IL-27 (R&D Systems).
Western blot analysis
Cells were lysed in lysis buffer [Tris 50 mM (pH 7.5), NaCl
300 mM, and Triton X-100 0.5%] supplemented with proteases
and phosphatase inhibitors. Protein concentration in the post-
nuclear lysates was measured by BCA Protein Assay (Pierce) and
equal amounts of protein lysates (60 mg) were loaded on 10%
SDS-PAGE. Gels were transferred on nitrocellulose using iBlot
Dry Blotting System (Invitrogen). Filters were blocked with 5% dry
skimmed milk and blotted with the following specific primary
antibodies: mouse monoclonal antibody to phosphorylated c-Jun
(Ser 63) (KM1) (Santa Cruz Biotechnologies) and to c-Src
(Upstate); rabbit polyclonal antibodies to c-Jun, IRF1 (Santa Cruz
Biotechnologies), phosphorylated c-Src, ERK1/2 and phosphor-
ylated ERK1/2 (Thr 201/Tyr 204) (Cell Signaling); antiserum to
actin (Sigma); rabbit antiserum to IkB (a gift of Dr Antonio
Leonardi, University of Naples, Italy). Blots were then incubated
with the appropriate HRP-conjugated secondary antiserum
(Jackson Immunoresearch), and revealed with the WestPico
chemiluminescence system (Pierce). Filters were stripped for
10 min with ReBlot Plus Strong Antibody Stripping Solution
(Millipore).
Microarray analysis and quantitative real-time PCR
Total RNA from human MoDC was extracted with Rneasy
Mini Kit (Qiagen, Hilden, Germany). For quantitative real-time-
PCR (qRT-PCR) experiments cDNA was synthesized using the
SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen).
qRT-PCR was performed using iQ SYBRGreen SuperMix
(Biorad). For the microarray analysis total RNA was amplified
using the Agilent Low RNA Input Linear Amplification kit. In a
first experiment RNA obtained from MoDC from three
independent donors stimulated with PolyI:C (20 mg/ml) or R848
(10 mM) for 4 hours were labeled using Cy5 and co-hybridized
with RNA from unstimulated MoDC labelled with Cy3. In a
second set of experiments total RNA from MoDC from the same
donors stimulated with PolyI:C (20 mg/ml) or R848 (10 mM) in the
presence of PP2 (20 mM) was labelled with Cy3 and co-hybridized
with Cy-5 labeled RNA from cells stimulated by the same amount
of PolyI:C or R848 in the absence of PP2. In all experiments
400 ng of total RNA was used as starting material. The efficiency
of incorporation of the Cy5 or Cy3 dye was measured by
NanoDrop analysis. Equal amounts of labelled Cy5 and Cy3
cRNAs were co-hybridized onto the Agilent Technologies 44K
whole human genome microarray, detecting over 40,000 tran-
scripts, for 17 hours at 65uC following the Agilent protocol. Raw
images were first analyzed by using the GenePix 6.0 software
(Molecular Devices), and the data were then transferred to the
BASE 1.2 database/analysis software. For each spot, local
background was subtracted from the mean fluorescence intensity
of the Cy3 and Cy5 dyes. Spot intensities were then normalized by
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channels were filtered. The average intensity ratio of repeated
spots from three experimental replicates was estimated by
geometric mean. The accuracy and statistical significance of the
observed ratios were determined using the Student’s t-test. The
complete set of microarray data has been submitted to the Array
ExpressdatabaseEMBL-EBI (http://www.ebi.ac.uk/arrayexpress/)
with accession number E-TABM-1018.
Statistical analysis
One tail paired Student’s t-test was performed to evaluate
statistically significant differences between two groups. A p value
,0.05 was considered statistically significant.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0011491.s001 (0.11 MB
XLS)
Table S2
Found at: doi:10.1371/journal.pone.0011491.s002 (0.11 MB
XLS)
Figure S1 c-Src kinase is activated upon stimulation with R848
and PolyI:C. Human MoDC were pretreated or not with PP2
(20 mM) and stimulated with PolyI:C (20 mg/ml) or R848 (10 mM)
for the indicated time. Phosphorylated (Y418) c-Src was detected
by WB on total cell lysates. After stripping filter was re-blotted with
an antibody directed against total c-Src.
Found at: doi:10.1371/journal.pone.0011491.s003 (1.06 MB TIF)
Figure S2 Src kinases inhibition results in impaired IFNb
production. Human MoDC were pretreated or not with PP2
(20 mM) and stimulated with PolyI:C (20 mg/ml). After 24 hours
IFNb released in the supernatants was detected using a Mesoscale
assay. Fold induction for the levels of IFN-beta compared to
unstimulated cells is plotted. Three independent experiments and
the p values for differences between the groups are shown (p value
,0.05 is significant).
Found at: doi:10.1371/journal.pone.0011491.s004 (0.63 MB TIF)
Figure S3 Src kinases are required for accumulation of c-Jun
and IRF1. Human MoDC were pretreated or not with PP2
(20 mM) and stimulated with PolyI:C (20 mg/ml) or R848 (10 mM)
for the indicated time. IkB, phospho-ERK, phospho-cJun and
IRF1 were detected by WB on total cell lysates. After stripping
filters were re-blotted with antibodies to actin, total ERK, total
cJun and actin, respectively. (A) Intensity of the bands in Figure 2
of the manuscript was quantified by Image J and represented as
fold induction over samples from unstimulated cells. (B) Densio-
metric analysis of WB detection for p-cJun, cJun, IRF1 and IkB
from three independent experiments. For each experiment fold
induction over samples from unstimulated cells were normalized to
actin expression and plotted. The p values for differences between
the groups are shown (p value ,0.05 is significant).
Found at: doi:10.1371/journal.pone.0011491.s005 (1.50 MB TIF)
Figure S4 IL-12p70 production is inhibited even at low
concentrations of PP2. Human MoDC were pretreated with the
indicated doses of PP2 for 20 minutes at 37uC, and then stimulated
with PolyI:C (20 mg/ml) or R848 (10 mM). After 24 hours
supernatants were collected and IL-12p70 and IL-23 were
measured by Mesoscale or ELISA, respectively.
Found at: doi:10.1371/journal.pone.0011491.s006 (1.11 MB TIF)
Figure S5 Comparison between expression levels of IL-12
subunits. (A) MoDC were pretreated or not with PP2 (20 mM)
and stimulated with PolyI:C (20 mg/ml) or R848 (10 uM). qRT-
PCR for IL-12A gene was performed after 4 hours of stimulation
and expressed as fold increase over basal expression in
unstimulated cells. (B) A comparison between IL-12A and IL-
12B mRNA levels. Numbers on each column indicate values of
fold induction. Data are representative of at least three
experiments.
Found at: doi:10.1371/journal.pone.0011491.s007 (1.13 MB TIF)
Figure S6 Src kinases inhibition does not affect IL-27 produc-
tion. Human MoDC were pretreated or not with PP2 (20 mM) and
stimulated with PolyI:C (20 mg/ml) or R848 (10 mM). IL-27
released in the supernatants was detected after 24 hours of
stimulation, by ELISA. Fold induction of IL-27 compared to
unstimulated cells is plotted. Three independent experiments and
the p values for differences between the groups are shown (p value
,0.05 is significant).
Found at: doi:10.1371/journal.pone.0011491.s008 (0.88 MB TIF)
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